|
|
|
Volumn 18, Issue 3, 1997, Pages 157-160
|
|
The management of ovarian cancer: An update
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIMITOTIC AGENT;
ANTINEOPLASTIC AGENT;
CISPLATIN;
CYCLOPHOSPHAMIDE;
PACLITAXEL;
PROTEIN P53;
CANCER CHEMOTHERAPY;
CANCER STAGING;
CANCER SURVIVAL;
DIAGNOSTIC ACCURACY;
DOPPLER FLOWMETRY;
EARLY DIAGNOSIS;
ECHOGRAPHY;
EDITORIAL;
FEMALE;
FOLLOW UP;
HIGH RISK PATIENT;
HUMAN;
MEDICAL ETHICS;
OVARY CANCER;
PROGNOSIS;
QUALITY OF LIFE;
SURGICAL TECHNIQUE;
ANTINEOPLASTIC AGENTS;
COMBINED MODALITY THERAPY;
FEMALE;
HUMANS;
OVARIAN NEOPLASMS;
OVARIECTOMY;
PROGNOSIS;
|
|
EID: 0030917480
PISSN: 03922936
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (5)
|
|
References (15)
|